Scarica l'app Stockscreener
14.69
2.20%
-0.33
Dopo l'orario di chiusura:
15.07
0.38
+2.59%
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
What drives Elanco Animal Health Incorporated stock priceLightning-fast growth - PrintWeekIndia
Elanco Secures Major EU Victory: New Once-Daily Dog Dermatitis Drug Matches Market Leader in Clinical Trial - Stock Titan
Elanco Animal Health Incorporated Stock Analysis and ForecastUnprecedented growth rates - Autocar Professional
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $18.00 - MarketBeat
Aquatic Veterinary Market Set to Witness Significant Growth - openPR.com
Autogenous Vaccine for Aquaculture Market Generated - openPR.com
ELANCO SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Elanco Animal Health Inc. (NYSE:ELAN) And Encourages Long-Term Investors to Contact the FirmELAN - ACCESS Newswire
Is Elanco Animal Health Incorporated a good long term investmentHigh-profit trading signals - jammulinksnews.com
What analysts say about Elanco Animal Health Incorporated stockMassive portfolio appreciation - jammulinksnews.com
Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com
Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance
Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World
Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - Defense World
Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World
Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest
Veterinary Parasiticides Market Size to Hit USD 21.77 Billion by 2034 - Precedence Research
Bank of New York Mellon Corp Sells 47,745 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Nisa Investment Advisors LLC Sells 70,629 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Leerink upgrades Elanco on pet health momentum, downgrades Zoetis By Investing.com - Investing.com Canada
Elanco Animal Health Inc (ELAN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
This Mondelez International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Leerink Partners upgrades Elanco Animal Health stock rating to Outperform By Investing.com - Investing.com Canada
Elanco (ELAN) Upgraded on Promising Pet Health Launches and Grow - GuruFocus
Elanco launches cattle respiratory vaccine - Beef Magazine
BiomEdit raises $18.4m Series B to expand designer probiotics platform - AgFunderNews
Are Options Traders Betting on a Big Move in ELAN Stock? - TradingView
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View
Elanco's dog flu vaccine gets USDA nod - MSN
Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today
Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha
USDA Approves Elanco's New Vaccine for Canine Influenza - MarketScreener
Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire
Revolutionary Canine Flu Vaccine Shows 100% Protection: Elanco's New TruCan Ultra Gets USDA Green Light - Stock Titan
Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire
Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the Firm - GlobeNewswire
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq
The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts - Benzinga
5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Rating Increased to Outperform at William Blair - MarketBeat
3.25%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):